Home / business / Glenmark Begins Phase 3 of Clinical Trials on Antiviral Favipiravir for Covid-19 Patients in India

Glenmark Begins Phase 3 of Clinical Trials on Antiviral Favipiravir for Covid-19 Patients in India

-
As per the approved clinical trial protocol, 150 subjects with mild to moderate Covid-19 will be randomised in the study in a 1:1 ratio to Favipiravir with standard supportive care or standalone standard supportive care.

from Top Business News- News18.com
Read The Rest:timesnownews...
Glenmark Begins Phase 3 of Clinical Trials on Antiviral Favipiravir for Covid-19 Patients in India Glenmark Begins Phase 3 of Clinical Trials on Antiviral Favipiravir for Covid-19 Patients in India Reviewed by Team Exprssnews on May 11, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.